We assessed noninferiority of a novel ultrathin strut drug-eluting stent releasing sirolimus from a biodegradable polymer ( Orsiro , O-SES ) compared with the durable polymer Xience Prime everolimus-eluting stent ( X-EES ) in terms of the primary end point in-stent late lumen loss at @ months .